Article Details
Retrieved on: 2018-04-14 12:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Two Sigma Investments</b> LP lowered its position in PDL Biopharma (NASDAQ:PDLI) by 25.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 875,481 shares of the biotechnology company's stock after selling ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here